China: Pathology Consults and Health Care Collaboration
In April 2011, UPMC entered a definitive agreement with KingMed Diagnostics, the largest independent medical diagnostic laboratory in China.
Headquartered in Guangzhou, KingMed's 17 central laboratories serve more than 6,000 hospitals and clinics in 26 out of 33 provincial-level regions in China.
Through this partnership, UPMC’s Department of Pathology provides second opinions for high-acuity anatomical pathology cases. Using equipment that scans glass pathology slides and stores and transmits the images electronically, KingMed receives second opinions on patient diagnoses from our UPMC pathologists through a secure, web-based telepathology portal.
The agreement provides KingMed's patients with rapid access to UPMC’s expert pathologists, thereby helping to ensure accurate diagnoses of complex diseases.
Pathology training and education
UPMC’s collaboration with KingMed also is expected to include training for pathologists from China in UPMC’s Pittsburgh facilities and joint academic meetings as part of ongoing medical education in China.
U.S.-China Healthcare Cooperation Program (HCP)
UPMC is a founding member of the U.S.-China Healthcare Cooperation Program (HCP), a public-private partnership of 18 companies and 10 nonprofit organizations.
Supported by United States governmental agencies and the Chinese ministries of health and commerce, HCP is a vehicle for the two countries to work together in:
- Technical collaboration
- Capacity building
- Market development
HCP will support projects in:
- Health care information technology
- Rural health care initiatives
- Quality and safety
- Hospital management for Chinese health care investment priorities